All Blogs

Apr 08, 2021

Artios collaborates with Novartis; Scholar Rock eyes Phase III trial; Novavax starts crossover arms in Covid-19 trials; Volastra nabs $44M


Apr 07, 2021

E-Pharmacies: A Disruptive Innovation and the Future of Pharma Sector


Apr 06, 2021

Cidara Therapeutics and J&J’s USD 780M Deal; FDA’s Approval to Supernus’s ADHD drug; Rain Therapeutics USD 100M IPO; NMPA Approval to Antengene’s ATG-019 IND Application


Apr 01, 2021

Amgen to acquire Rodeo for $55M; Novartis expands radioligand portfolio; Organon acquires Alydia for $240M; Forma announces positive FT-4202 dose levels


Mar 31, 2021

How Depression Is Eroding The Mental And The Physical Health Of The Society?


Apr 05, 2021

Kinase Inhibitors: Challenging the established Biologics as the new standard of care in autoimmune diseases?


Mar 30, 2021

Bright Peak, Ajinomoto to Create Novel Immunocytokines; FDA’s Rejection to Lilly/Pfizer’s Tanezumab for Osteoarthritis Pain; Ikena Oncology Unveils IPO Pricing


Apr 02, 2021

A New Addition to Existing Chimeric Antigen Receptor Therapies –Potential for a Game Changer in Blood Cancers


Mar 29, 2021

Ever-Evolving Market Landscape of Transcatheter Aortic Valve Replacement


Mar 26, 2021

How Will New Discoveries of Deep Brain Stimulation Devices Transform the Pharma Domain?